Search research articles
お問い合わせ
Search research articles
Search
関連する実験動画
高齢者における落下.
P Nisipeanu
,
R Inzelberg
Lancet (London, England)
|
April 19, 1997
日本語
まとめ
No abstract available in
PubMed
.
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
すべて
12
Same author
6
Same journal
6
Same author
Cutaneous squamous cell carcinoma and the PARK2 gene.
The British journal of dermatology
·
2017
Same author
Exploring determinants of progression in Parkinson's disease. Is there a difference among Jewish ethnic groups?
Parkinsonism & related disorders
·
2015
Same author
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.
Neurology
·
2012
Same author
High prevalence of malignant melanoma in Israeli patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996)
·
2011
Same author
Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel.
Neuroepidemiology
·
2009
Same author
Survival in Parkinson's disease: the effect of dementia.
Parkinsonism & related disorders
·
2008
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)
·
2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)
·
2026
Same journal
Research priorities for characterising Bundibugyo virus.
Lancet (London, England)
·
2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)
·
2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)
·
2026
Same journal
Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.
Lancet (London, England)
·
2026
関連記事をすべて見る